APA (7th ed.) Citation

Tian, Y., Shi, W., Wang, J., Zhang, W., Xia, L., Gao, L., . . . Chen, Y. (2025). Exosomal PD-L1 and lactate versus tissue PD-L1 as biomarkers for clinical outcomes of PD-1 Blockade plus chemotherapy in metastatic esophagogastric signet ring cell carcinoma. Experimental Hematology & Oncology, 14(1), 1. https://doi.org/10.1186/s40164-025-00615-w

Chicago Style (17th ed.) Citation

Tian, Yuanyuan, et al. "Exosomal PD-L1 and Lactate Versus Tissue PD-L1 as Biomarkers for Clinical Outcomes of PD-1 Blockade Plus Chemotherapy in Metastatic Esophagogastric Signet Ring Cell Carcinoma." Experimental Hematology & Oncology 14, no. 1 (2025): 1. https://doi.org/10.1186/s40164-025-00615-w.

MLA (9th ed.) Citation

Tian, Yuanyuan, et al. "Exosomal PD-L1 and Lactate Versus Tissue PD-L1 as Biomarkers for Clinical Outcomes of PD-1 Blockade Plus Chemotherapy in Metastatic Esophagogastric Signet Ring Cell Carcinoma." Experimental Hematology & Oncology, vol. 14, no. 1, 2025, p. 1, https://doi.org/10.1186/s40164-025-00615-w.